Anti-oestrogen therapy in the treatment of desmoid tumours: A systematic review

Colorectal Disease

Volumn 13, Issue 12, 2011, Pages

  Bocale, D ^a   Rotelli, M T ^a   Cavallini, A ^b   Altomare, D F ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Anti oestrogen therapy; Desmoid tumours; Tamoxifen; Toremifene

Indexed keywords

ALPHA2B INTERFERON; CELECOXIB; DICLOFENAC; ESTROGEN RECEPTOR; GOSERELIN; IBUPROFEN; INDOMETACIN; MEGESTROL ACETATE; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RALOXIFENE; SULINDAC; TAMOXIFEN; TOREMIFENE;

CANCER COMBINATION CHEMOTHERAPY; DESMOID TUMOR; DRUG EFFICACY; GARDNER SYNDROME; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; FIBROMATOSIS, AGGRESSIVE; HUMANS; TAMOXIFEN; TOREMIFENE;

EID: 80755155824     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02758.x     Document Type: Review

References (53)

1. Duggal A, Dickinson IC, Sommerville S, Gallie P. The management of extra-abdominal desmoid tumours. Int Orthop 2004; 28: 252-6.
2. Gwynne-Jones DP, Theis JC, Jeffery AK, Hung NA. Long-term follow-up of a recurrent multifocal desmoid tumour treated with tamoxifen: a case report. J Orthop Surg 2005; 13: 174-7.
3. Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol 2010; 5: 380-4.
4. Kulaylat MN, Karakousis CP, Keaney CM, McCorvey D, Bem J, Ambrus JL Sr. Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol 1999; 25: 487-97.
5. Ibrahim M, Sandogji H, Allam A. Huge intrathoracic desmoid tumor. Ann Thorac Med 2009; 4: 146-8.
6. Knudsen AL, Bülow S. Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer 2001; 1: 111-9.
7. Sturt NJH, Clark SK. Current ideas in desmoid tumours. Fam Cancer 2006; 5: 275-85.
8. Hansmann A, Vogel CAT, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100: 612-20.
9. Eisenhauera EA, Therasseb P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47.
10. Ristic D, Tomasevic Z. Therapy of aggressive fibromatosis is still an open question: a series of patients treated at a single institution. Fertil Steril 2005; 84: 509.
11. Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983; 52: 2201-4.
12. Procter H, Singh L, Baum M, Brinkley D. Response of multicentric desmoid tumors to tamoxifen. Br J Surg 1987; 74: 401.
13. Lackner H, Urban C, Benesch M et al. Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study. J Pediatr Hematol Oncol 2004; 26: 518-22.
14. Soon JL, Lau WK, Seow-Choen F, Cheng CW. Unresectable desmoid tumours causing obstructive uropathy in familial adenomatous polyposis. Asian J Surg 2005; 28: 233-7.
15. Nishioka M, Miura S, Fujita M et al. Pelvic desmoid with complete remission after excision for recurrence. Teikyo Med J 2000; 23: 155-9.
16. Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC. Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984; 66A: 1369-74.
17. Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer 1991; 67: 1443-6.
18. Thomas S, Datta-Gupta S, Kapur BM. Treatment of recurrent desmoid tumours with tamoxifen. Aust NZ J Surg 1990; 60: 919-21.
19. Chao A-S, Lai C-H, Hsueh S, Chen C-S, Yang Y-C, Soong Y-K. Successful treatment of recurrent pelvic desmoid tumour with tamoxifen. Hum Reprod 2000; 15: 311-3.
20. Lev D, Kotilingam D, Wei C et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007; 25: 1785-91.
21. Izes JK, Zinman LN, Larsen CR. Regression of large pelvic desmoid tumor by tamoxifen and sulindac. Urology 1996; 47: 756-9.
22. Ferah Y, Ayse K, Mustafa C, Ugur S, Murat G, Lale AI. Possible therapeutic role of vitamin D3 in aggressive fibromatosis. Jpn J Clin Oncol 2004; 34: 472-5.
23. Benson JR, Mokbel K, Baum M. Management of desmoid tumors including a case report of toremifene. Ann Oncol 1994; 5: 173-7.
24. Tonelli F, Ficari F, Valanzano R, Brandi ML. Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori 2003; 89: 391-6.
25. Cohen S, Ad-El D, Benjaminov O, Gutman H. Post-traumatic soft tissue tumors: case report and review of the literature a propos a Post-traumatic paraspinal desmoid tumor. World J Surg Oncol 2008; 6: 28.
26. Richard HM, Thall EH, Mitty H. Desmoid tumor-ureteral fistula in Gardner's syndrome. Urology 1997; 49: 135-8.
27. Risum S, Bulow S. Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 2003; 5: 585-6.
28. Eagel BA, Zentler-Munro P, Smith IE. Mesenteric desmoid tumours in Gardner's syndrome review of medical treatments. Postgrad Med J 1989; 65: 497-501.
29. Wilcken N, Tattersall MHN. Endocrine therapy for desmoid tumors. Cancer 1991; 68: 1384-8.
30. Mukherjee A, Malcolm A, De la Hunt M, Neal DE. Pelvic fibromatosis (desmoid) treatment with steroids and tamoxifen. Br J Urol 1995; 75: 559-60.
31. Ohashi T, Shigematsu N, Kameyama K, Kubo A. Tamoxifen for recurrent desmoid tumor of the chest wall. Int J Clin Oncol 2006; 11: 150-2.
32. Tulchinsky H, Keidar A, Strul H, Goldman G, Klausner JM, Rabau M. Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg 2005; 140: 159-63.
33. Wcislo G, Szarlej-Wcislo K, Szczylik C. Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature. J Cancer Res Clin Oncol 2007; 133: 533-8.
34. Lackner H, Urban C, Kerbl R, Schwinger W, Beham A. Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer 1997; 80: 334-40.
35. Maseelall P, Robins JC, Williams DB, Thomas MA. Stabilization and regression of a recurrent desmoid tumor with the antiestrogen toremifene. Fertil Steril 2005; 84: 509.
36. Bulow S. Sulindac and tamoxifen in the treatment of desmoid tumours in patients with familial adenomatous polyposis. Colorectal Dis 2001; 3: 266-7.
37. Clark CP, Vanderpool D, Preskitt T. The response of retroperitoneal fibrosis to tamoxifen. Surgery 1991; 109: 502-6.
38. Heidemann J, Ogawa H, Otterson MF, Shidham VB, Binion DG. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum 2004; 47: 118-22.
39. Brooks MD, Ebbs SR, Colletta AA, Baum M. Desmoid tumours treated with triphenylethylenes. Eur J Cancer 1992; 28: 1014-8.
40. Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363-9.
41. Waddell WR, Gerner RE, Reich MP. Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 1983; 22: 197-211.
42. Carneiro C, Hurtubis C, Singh M, Robinson W. Desmoid tumors of the right rectus abdominus muscle in postpartum women. Arch Gynecol Obstet 2009; 279: 869-73.
43. Bauernhofer T, Stöger H, Schmid M et al. Sequential treatment of recurrent mesenteric desmoid tumor. Cancer 1996; 77: 1061-5.
44. Brivio F, Fumagalli L, Lissoni P, Rovelli F, Colzani M, Denova M. Desmoid tumours therapeutic approach in relation to pathogenesis. Cancer Ther 2009; 7: 103-8.
45. Altomare DF, Rotelli MT, Rinaldi M et al. Potential role of the steroid receptor pattern in the response of inoperable intra-abdominal desmoid to toremifene after failure of tamoxifen therapy. Int J Colorectal Dis 2010; 25: 787-9.
46. De Camargo VP, Keohan ML, D'Adamo DR et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010; 116: 2258-65.
47. Ezumi K, Yamamoto H, Takemasa I et al. Dacarbazine-doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case. Jpn J Clin Oncol 2008; 38: 222-6.
48. Lynch HT, Fitzgibbons R Jr, Chong S et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994; 37: 260-7.
49. Santos GAC, Cunha IW, Rocha RM et al. Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. Biosci Trends 2010; 4: 25-30.
50. Zhang HY, Ke Q, Zhang Z et al. Expression of beta-catenin and estrogen receptor in desmoid-type fibromatosis. Sichuan Da Xue Xue Bao Yi Xue Ban 2010; 41: 101-5.
51. Balducci C, Lilli C, Stabellini G et al. Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene. BMC Cancer 2005; 5: 22.
52. Locci P, Bellocchio S, Lilli C et al. Synthesis and secretion of transforming growth factor-beta1 by human desmoid fibroblast cell line and its modulation by toremifene. J Interferon Cytokine Res 2001; 21: 961-70.
53. Burstein HJ, Prestrud AA, Seidenfeld J et al. American Society of Clinical Oncology Clinical Practice Guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 2010; 23: 3784-96.